Testing disagreements hamper Ebola vax search; Admedus begins PhII trial of herpes jab;

> As the Ebola outbreak wanes, disagreements over the most effective testing methods may mean potential vaccines aren't thoroughly vetted. Story

> Admedus Limited will begin a Phase II study of its herpes vaccine this month. More

> Research Triangle Park, NC-based Argos Therapeutics ($ARGS) struck a deal with China-based Lummy Hong Kong to develop cancer immunotherapies in China. Report

> Daiichi Sankyo and Terumo announced their application for manufacturing and sales approval of an intradermal seasonal influenza vaccine in Japan. Release

> GeoVax will seek a dual pathway for advancing its HIV vaccine into human trials. Release

> Scientists believe a new HIV treatment pioneered using an antibody to attack the virus could lead to a vaccine to prevent the infection. Story

And Finally... Los Angeles artist Mary Beth Heffernan delivered a way for Ebola patients to see the faces of those helping. Story